Long-Term Use of Temozolomide as Safe and Effective Therapy for an Aggressive Corticotroph Adenoma in a Very Old Patient.
Maria Chiara DecaroliAnna AnsaloniMaria Laura MonzaniMarco LosaElena ZunarelliVincenzo RochiraBruno MadeoPublished in: Journal of the Endocrine Society (2021)
Our case supports the long-term use of TMZ, confirming its safety and efficacy also for elderly patients.
Keyphrases